La Jolla Pharmaceutical Company logo
La Jolla Pharmaceutical Company LJPC

Quartalsbericht 2022-Q2
hinzugefügt 15.08.2022

report update icon

La Jolla Pharmaceutical Company Langfristiger Schuldenstrom 2011-2026 | LJPC

Langfristiger Schuldenstrom Jährlich La Jolla Pharmaceutical Company

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
154 K 204 K 2.77 M - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
2.77 M 154 K 1.04 M

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Celldex Therapeutics Celldex Therapeutics
CLDX
1.55 M $ 34.55 2.04 % $ 2.29 B usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 4.47 12.59 % $ 10.8 B australiaAustralia
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Aligos Therapeutics Aligos Therapeutics
ALGS
3.58 M $ 6.68 -12.79 % $ 66 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
45.5 M $ 309.66 -3.27 % $ 40.6 B usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
7.93 M $ 22.88 4.91 % $ 1.07 B usaUSA
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
BioNTech SE BioNTech SE
BNTX
45 M $ 102.92 0.78 % $ 27.2 B germanyGermany
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 3.04 -1.3 % $ 5 M israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
215 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
65 K $ 1.15 7.48 % $ 14 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
3.55 M $ 1.41 4.07 % $ 363 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
631 K $ 4.32 1.41 % $ 462 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 24.53 1.41 % $ 3.12 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
208 K - -2.5 % $ 5.88 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
3.46 M $ 3.44 -2.27 % $ 346 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.6 -0.62 % $ 426 M britainBritain
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
21.2 M - - $ 546 M usaUSA
Citius Pharmaceuticals Citius Pharmaceuticals
CTXR
242 K $ 0.86 0.39 % $ 5.79 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Cidara Therapeutics Cidara Therapeutics
CDTX
1.38 M - - $ 1.41 B usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
7 K - - $ 3.45 B usaUSA